Crinetics Pharmaceuticals
Trade Crinetics Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRNX
Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.
CRNX Key Statistics
Stock Snapshot
The current Crinetics Pharmaceuticals(CRNX) stock price is $49.32, with a market capitalization of 4.68B. The stock trades at a price-to-earnings (P/E) ratio of -10.88.
Crinetics Pharmaceuticals(CRNX) stock opened on 2025-12-16 at $50.67. The price climbed to — and dipped to —.
Crinetics Pharmaceuticals(CRNX) shares are trading with a volume of 0, against a daily average of 1.02M.
During the past year, Crinetics Pharmaceuticals(CRNX) stock moved between $24.10 at its lowest and $56.15 at its peak.
During the past year, Crinetics Pharmaceuticals(CRNX) stock moved between $24.10 at its lowest and $56.15 at its peak.
CRNX News
Crinetics Pharmaceuticals (CRNX) just hit an important milestone, as it has dosed the first patient in its Phase 1/2 BRAVESST2 trial of CRN09682 for SST2 positi...
